Xcellerate® is an advanced amniotic membrane allograft with an extracellular matrix providing robust wound coverage. As part of New Horizon Medical Solutions’ biologics portfolio — and originally developed through the innovation of Precise Bioscience — Xcellerate® provides a robust scaffold ideal for wounds requiring enhanced structural integrity and support.

The product’s handling, prolonged wound coverage, and resilience make it a powerful tool for both outpatient and surgical wound care protocols.